Retrospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Apr 21, 2017; 23(15): 2743-2749
Published online Apr 21, 2017. doi: 10.3748/wjg.v23.i15.2743
Table 3 Performance of 18-fluoro-2-deoxyglucose positron emission tomography for esophageal cancer screening
Esophageal cancer(+) (n = 28)Esophageal cancer(-) (n = 14762)PPV, NPV
FDG-PET positive (n = 51)150PPV 2.0%
(95%CI: 0.0-10.4)
FDG-PET negative (n = 14739)2714712NPV 99.8%
(95%CI: 99.7-99.9)
Sensitivity, specificitySensitivity 3.6%Specificity 99.7%
(95%CI: 0.1-18.3)(95%CI: 99.6-99.7)